BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//talks.cam.ac.uk//v3//EN
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:19700329T010000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:19701025T020000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
CATEGORIES:Department of Pharmacology Seminar Series
SUMMARY:Pharmacology Seminar Series: Natalie Krahmer\, Elu
 cidating the Cell Architecture of Metabolic Liver 
 Disease via Spatial Proteomics - Natalie Krahmer\,
  Helmholtz Diabetes Center 
DTSTART;TZID=Europe/London:20251031T130000
DTEND;TZID=Europe/London:20251031T140000
UID:TALK234973AThttp://talks.cam.ac.uk
URL:http://talks.cam.ac.uk/talk/index/234973
DESCRIPTION:Friday 31 October\, 13:00 - 14:00\n\nSpeaker: Nata
 lie Krahmer\, Helmholtz Diabetes Center \n\nTalk T
 itle: Elucidating the Cell Architecture of Metabol
 ic Liver Disease via Spatial Proteomics\n\nBiograp
 hy: Natalie Krahmer is an Emmy Noether Group Leade
 r at the Institute of Diabetes and Obesity\, Helmh
 oltz Center Munich. She earned her doctorate in bi
 ology in 2011 at the Max Planck Institute of Bioch
 emistry under the mentorship of Dr. Tobias Walther
  and completed postdoctoral training with Dr. Matt
 hias Mann\, specializing in proteomics and systems
  biology. Natalie Krahmer’s research explores how 
 cellular architecture adapts to lipid accumulation
  in metabolic diseases. She has developed advanced
  multi-omic workflows to map organelle organizatio
 n in vivo and has applied these tools to make disc
 overies in lipid droplet biology\, metabolic liver
  disease and adipocyte biology. She has been award
 ed the 2025 Helmholtz Female Professorship and the
  2020 EFSD/Novo Nordisk Future Leader Award.
LOCATION:Seminar Room (Level 2)\, Dept of Pharmacology 
CONTACT:
END:VEVENT
END:VCALENDAR